A549 cells were used as a lung cancer model, since lung cancer is a frequent comorbidity in COPD and therefore share common pathogenic pathways (Adcock et al., 2011; Yang et al., 2011) including the therapeutic potential of PDE4 targeting (Pullamsetti et al., 2013). This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.